vs
维珍大西洋航空（ATLN）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
Orthofix Medical Inc.的季度营收约是维珍大西洋航空的1.8倍（$219.9M vs $120.0M），Orthofix Medical Inc.净利率更高（-1.0% vs -22.6%，领先21.6%），Orthofix Medical Inc.同比增速更快（2.0% vs -7.3%），Orthofix Medical Inc.自由现金流更多（$16.8M vs $-8.2M），过去两年维珍大西洋航空的营收复合增速更高（9.2% vs 8.0%）
维珍大西洋航空（简称维珍航空）是英国知名航空公司，总部位于英格兰西萨塞克斯郡克劳利。该公司成立于1984年，最初名为不列颠大西洋航空，创始人原本计划开通伦敦至福克兰群岛的航线，更名后创始人之一将股份售予理查德·布兰森，如今是英国航空市场的核心运营商之一。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
ATLN vs OFIX — 直观对比
营收规模更大
OFIX
是对方的1.8倍
$120.0M
营收增速更快
OFIX
高出9.3%
-7.3%
净利率更高
OFIX
高出21.6%
-22.6%
自由现金流更多
OFIX
多$25.0M
$-8.2M
两年增速更快
ATLN
近两年复合增速
8.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $120.0M | $219.9M |
| 净利润 | $-27.1M | $-2.2M |
| 毛利率 | 9.1% | 71.1% |
| 营业利润率 | -19.5% | 0.2% |
| 净利率 | -22.6% | -1.0% |
| 营收同比 | -7.3% | 2.0% |
| 净利润同比 | 60.5% | 92.4% |
| 每股收益（稀释后） | $-0.48 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ATLNOFIX
| Q4 25 | $120.0M | $219.9M | ||
| Q3 25 | $110.1M | $205.6M | ||
| Q2 25 | $102.9M | $203.1M | ||
| Q1 25 | $102.8M | $193.6M | ||
| Q4 24 | $129.5M | $215.7M | ||
| Q3 24 | $107.8M | $196.6M | ||
| Q2 24 | $104.6M | $198.6M | ||
| Q1 24 | $100.6M | $188.6M |
净利润ATLNOFIX
| Q4 25 | $-27.1M | $-2.2M | ||
| Q3 25 | $-10.8M | $-22.8M | ||
| Q2 25 | $-10.7M | $-14.1M | ||
| Q1 25 | $-10.7M | $-53.1M | ||
| Q4 24 | $-68.7M | $-29.1M | ||
| Q3 24 | $-7.0M | $-27.4M | ||
| Q2 24 | $-54.9M | $-33.4M | ||
| Q1 24 | $-4.9M | $-36.0M |
毛利率ATLNOFIX
| Q4 25 | 9.1% | 71.1% | ||
| Q3 25 | 11.3% | 72.2% | ||
| Q2 25 | 11.1% | 68.7% | ||
| Q1 25 | 10.9% | 62.8% | ||
| Q4 24 | 10.3% | 69.0% | ||
| Q3 24 | 11.0% | 68.7% | ||
| Q2 24 | 11.0% | 67.8% | ||
| Q1 24 | 10.4% | 67.5% |
营业利润率ATLNOFIX
| Q4 25 | -19.5% | 0.2% | ||
| Q3 25 | -7.9% | -8.3% | ||
| Q2 25 | -8.4% | -7.9% | ||
| Q1 25 | -9.2% | -25.2% | ||
| Q4 24 | -4.5% | -5.3% | ||
| Q3 24 | -6.0% | -9.6% | ||
| Q2 24 | -7.9% | -12.5% | ||
| Q1 24 | -1.1% | -15.6% |
净利率ATLNOFIX
| Q4 25 | -22.6% | -1.0% | ||
| Q3 25 | -9.8% | -11.1% | ||
| Q2 25 | -10.4% | -6.9% | ||
| Q1 25 | -10.5% | -27.4% | ||
| Q4 24 | -53.0% | -13.5% | ||
| Q3 24 | -6.5% | -13.9% | ||
| Q2 24 | -52.5% | -16.8% | ||
| Q1 24 | -4.8% | -19.1% |
每股收益（稀释后）ATLNOFIX
| Q4 25 | $-0.48 | $-0.05 | ||
| Q3 25 | $-0.20 | $-0.57 | ||
| Q2 25 | $-0.20 | $-0.36 | ||
| Q1 25 | $-0.20 | $-1.35 | ||
| Q4 24 | $-1.37 | $-0.76 | ||
| Q3 24 | $-0.16 | $-0.71 | ||
| Q2 24 | $-1.96 | $-0.88 | ||
| Q1 24 | $-0.19 | $-0.95 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $81.1K | $82.0M |
| 总债务越低越好 | $84.7M | — |
| 股东权益账面价值 | $-32.1M | $450.0M |
| 总资产 | $113.2M | $850.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ATLNOFIX
| Q4 25 | $81.1K | $82.0M | ||
| Q3 25 | $83.4K | $62.9M | ||
| Q2 25 | $374.7K | $65.6M | ||
| Q1 25 | $1.5M | $58.0M | ||
| Q4 24 | $678.7K | $83.2M | ||
| Q3 24 | $1.4M | $30.1M | ||
| Q2 24 | $439.5K | $26.4M | ||
| Q1 24 | $1.7M | $27.0M |
总债务ATLNOFIX
| Q4 25 | $84.7M | — | ||
| Q3 25 | $76.4M | $157.2M | ||
| Q2 25 | $75.4M | $157.0M | ||
| Q1 25 | $66.9M | $156.9M | ||
| Q4 24 | $80.6M | $157.0M | ||
| Q3 24 | $80.8M | $118.5M | ||
| Q2 24 | $78.5M | $118.0M | ||
| Q1 24 | — | $118.2M |
股东权益ATLNOFIX
| Q4 25 | $-32.1M | $450.0M | ||
| Q3 25 | $-22.1M | $442.5M | ||
| Q2 25 | $-18.5M | $458.3M | ||
| Q1 25 | $-14.0M | $458.3M | ||
| Q4 24 | $-12.0M | $503.1M | ||
| Q3 24 | $16.2M | $525.9M | ||
| Q2 24 | $23.0M | $546.0M | ||
| Q1 24 | $16.8M | $570.3M |
总资产ATLNOFIX
| Q4 25 | $113.2M | $850.6M | ||
| Q3 25 | $110.3M | $832.6M | ||
| Q2 25 | $106.8M | $837.2M | ||
| Q1 25 | $106.5M | $823.1M | ||
| Q4 24 | $119.8M | $893.3M | ||
| Q3 24 | $135.6M | $867.9M | ||
| Q2 24 | $134.2M | $882.0M | ||
| Q1 24 | $3.4M | $906.0M |
负债/权益比ATLNOFIX
| Q4 25 | — | — | ||
| Q3 25 | — | 0.36× | ||
| Q2 25 | — | 0.34× | ||
| Q1 25 | — | 0.34× | ||
| Q4 24 | — | 0.31× | ||
| Q3 24 | 4.98× | 0.23× | ||
| Q2 24 | 3.41× | 0.22× | ||
| Q1 24 | — | 0.21× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-8.2M | $27.7M |
| 自由现金流经营现金流 - 资本支出 | $-8.2M | $16.8M |
| 自由现金流率自由现金流/营收 | -6.8% | 7.6% |
| 资本支出强度资本支出/营收 | 0.0% | 4.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-4.5M | $-1.3M |
8季度趋势，按日历期对齐
经营现金流ATLNOFIX
| Q4 25 | $-8.2M | $27.7M | ||
| Q3 25 | $-1.3M | $12.4M | ||
| Q2 25 | $-9.5M | $11.6M | ||
| Q1 25 | $14.6M | $-18.4M | ||
| Q4 24 | $-426.3K | $23.7M | ||
| Q3 24 | $-1.3M | $11.7M | ||
| Q2 24 | $-15.5M | $9.0M | ||
| Q1 24 | $11.2M | $-18.6M |
自由现金流ATLNOFIX
| Q4 25 | $-8.2M | $16.8M | ||
| Q3 25 | $-1.3M | $2.5M | ||
| Q2 25 | $-9.5M | $4.5M | ||
| Q1 25 | $14.6M | $-25.1M | ||
| Q4 24 | $-449.4K | $15.2M | ||
| Q3 24 | $-1.4M | $6.3M | ||
| Q2 24 | $-15.5M | $-360.0K | ||
| Q1 24 | $11.2M | $-29.1M |
自由现金流率ATLNOFIX
| Q4 25 | -6.8% | 7.6% | ||
| Q3 25 | -1.2% | 1.2% | ||
| Q2 25 | -9.3% | 2.2% | ||
| Q1 25 | 14.2% | -13.0% | ||
| Q4 24 | -0.3% | 7.0% | ||
| Q3 24 | -1.3% | 3.2% | ||
| Q2 24 | -14.8% | -0.2% | ||
| Q1 24 | 11.2% | -15.4% |
资本支出强度ATLNOFIX
| Q4 25 | 0.0% | 4.9% | ||
| Q3 25 | 0.0% | 4.8% | ||
| Q2 25 | 0.0% | 3.5% | ||
| Q1 25 | 0.0% | 3.5% | ||
| Q4 24 | 0.0% | 4.0% | ||
| Q3 24 | 0.0% | 2.7% | ||
| Q2 24 | 0.0% | 4.7% | ||
| Q1 24 | 0.0% | 5.6% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ATLN
暂无分部数据
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
